SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001305328-04-000001
Filing Date
2004-10-12
Accepted
2004-10-12 11:44:26
Documents
1
Period of Report
2004-09-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3102
  Complete submission text file 0001305328-04-000001.txt   5207
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2500 WILCREST, 5TH FLOOR HOUSTON TX 77042
Business Address 713-780-4754
Bevan Dennis (Reporting) CIK: 0001305328 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 041073943